Company intelligence / Profile preview

Regal Intel

Edison, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Regal Intel is an active 501(c)(3) non-profit organization founded in 2001, providing regulatory, quality, and compliance solutions. They leverage AI-driven guidance to accelerate the development and accessibility of rare and orphan disease therapies for public good, specifically serving non-profit, academic, and public-interest partners globally. They operate as a consultancy and do not directly sponsor or develop therapeutics themselves.

Therapeutic areas: Rare Diseases
Industry: Consulting

Beyond the preview

Go deeper on Regal Intel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regal Intel.

Explore the full profile